These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28329311)

  • 1. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    Shay DK; Chillarige Y; Kelman J; Forshee RA; Foppa IM; Wernecke M; Lu Y; Ferdinands JM; Iyengar A; Fry AM; Worrall C; Izurieta HS
    J Infect Dis; 2017 Feb; 215(4):510-517. PubMed ID: 28329311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
    Izurieta HS; Thadani N; Shay DK; Lu Y; Maurer A; Foppa IM; Franks R; Pratt D; Forshee RA; MaCurdy T; Worrall C; Howery AE; Kelman J
    Lancet Infect Dis; 2015 Mar; 15(3):293-300. PubMed ID: 25672568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years.
    Lu Y; Chillarige Y; Izurieta HS; Wei Y; Xu W; Lu M; Sung HM; Lindaas A; Wernecke M; Macurdy T; Kelman J; Forshee RA
    J Infect Dis; 2019 Sep; 220(9):1511-1520. PubMed ID: 31290553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial.
    Gravenstein S; Davidson HE; Taljaard M; Ogarek J; Gozalo P; Han L; Mor V
    Lancet Respir Med; 2017 Sep; 5(9):738-746. PubMed ID: 28736045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2020 Jun; 222(2):278-287. PubMed ID: 32100009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season.
    Izurieta HS; Lu M; Kelman J; Lu Y; Lindaas A; Loc J; Pratt D; Wei Y; Chillarige Y; Wernecke M; MaCurdy TE; Forshee R
    Clin Infect Dis; 2021 Dec; 73(11):e4251-e4259. PubMed ID: 33211809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010-2015.
    Izurieta HS; Chillarige Y; Kelman JA; Forshee R; Qiang Y; Wernecke M; Ferdinands JM; Lu Y; Wei Y; Xu W; Lu M; Fry A; Pratt D; Shay DK
    Clin Infect Dis; 2018 Jul; 67(3):378-387. PubMed ID: 29438483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
    Young-Xu Y; Snider JT; van Aalst R; Mahmud SM; Thommes EW; Lee JKH; Greenberg DP; Chit A
    Vaccine; 2019 Mar; 37(11):1484-1490. PubMed ID: 30745146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Postinfluenza Deaths.
    Madaras-Kelly K; Remington R; Hruza H; Xu D
    J Infect Dis; 2018 Jun; 218(2):336-337. PubMed ID: 29237061
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15.
    Young-Xu Y; Thornton Snider J; Mahmud SM; Russo EM; Van Aalst R; Thommes EW; Lee JK; Chit A
    Euro Surveill; 2020 May; 25(19):. PubMed ID: 32431290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities.
    Nace DA; Lin CJ; Ross TM; Saracco S; Churilla RM; Zimmerman RK
    J Infect Dis; 2015 Jun; 211(12):1915-24. PubMed ID: 25525051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.
    Butler AM; Layton JB; Dharnidharka VR; Sahrmann JM; Seamans MJ; Weber DJ; McGrath LJ
    Am J Kidney Dis; 2020 Jan; 75(1):72-83. PubMed ID: 31378646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly.
    Foster DA; Talsma A; Furumoto-Dawson A; Ohmit SE; Margulies JR; Arden NH; Monto AS
    Am J Epidemiol; 1992 Aug; 136(3):296-307. PubMed ID: 1415151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
    Paudel M; Mahmud S; Buikema A; Korrer S; Van Voorhis D; Brekke L; Chit A
    Vaccine; 2020 Jun; 38(29):4548-4556. PubMed ID: 32446835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.
    Richardson DM; Medvedeva EL; Roberts CB; Linkin DR;
    Clin Infect Dis; 2015 Jul; 61(2):171-6. PubMed ID: 25829001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale.
    Gravenstein S; Dahal R; Gozalo PL; Davidson HE; Han LF; Taljaard M; Mor V
    Clin Trials; 2016 Jun; 13(3):264-74. PubMed ID: 26908539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.